Molecular Imaging in Tumor Angiogenesis and Drug Research
Author Information
Author(s): Xibo Ma, Jie Tian, Yang Xin, Qin Chenghu
Primary Institution: Intelligent Medical Research Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China
Hypothesis
Molecular imaging can enhance the understanding of tumor mechanisms and drug activity in the context of tumor angiogenesis and drug development.
Conclusion
Molecular imaging techniques can significantly improve the drug development process by providing more accurate and timely evaluations of tumor responses.
Supporting Evidence
- Molecular imaging can monitor biological processes at cellular and molecular levels in living subjects.
- BLI and FMI provide optical information for tumor evaluation.
- PET and SPECT can detect molecular changes before structural changes occur in tumors.
- Micro-CT provides high-resolution anatomical information for small animal imaging.
Takeaway
This study shows that special imaging techniques can help doctors see how tumors grow and how well treatments are working, making it easier to develop new medicines.
Methodology
The study reviews various molecular imaging modalities and their applications in tumor angiogenesis and drug research.
Limitations
Optical imaging techniques like BLI are limited to preclinical studies and cannot accurately locate inner bioluminescent sources.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website